GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (MIL:DIA) » Definitions » Selling, General, & Admin. Expense

Diasorin SpA (MIL:DIA) Selling, General, & Admin. Expense : €368 Mil (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Diasorin SpA's selling, general, & admin. expense for the three months ended in Dec. 2023 was €65 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2023 was €368 Mil.


Diasorin SpA Selling, General, & Admin. Expense Historical Data

The historical data trend for Diasorin SpA's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Selling, General, & Admin. Expense Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 205.17 216.15 296.34 364.79 368.13

Diasorin SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.79 101.40 101.90 100.00 65.13

Competitive Comparison of Diasorin SpA's Selling, General, & Admin. Expense

For the Diagnostics & Research subindustry, Diasorin SpA's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Selling, General, & Admin. Expense Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Selling, General, & Admin. Expense falls into.



Diasorin SpA Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €368 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA  (MIL:DIA) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Diasorin SpA Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA (MIL:DIA) Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.

Diasorin SpA (MIL:DIA) Headlines

From GuruFocus

NISSAY ASSET MANAGEMENT CORP /JAPAN/ /ADV Buys 1, Sells 4 in 1st Quarter

By GuruFocus Research GuruFocus Editor 05-19-2022

CADINHA & CO LLC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-05-2022